FDA Approves Swine Flu Vaccine

Washington, DC (AHN) – The U.S. Food and Drug Administration approved a H1N1, or swine flu, vaccine, this week.

The vaccines will likely be distributed nationally within the next four weeks.

The drugs are made by CSL Limited, MedImmune LLC, Novartis Vaccines and Diagnostic Limited and Sanofi Pasteur Inc.

The FDA said in a statement that the 2009 swine flu vaccines should begin protecting against the illness eight to 10 days after a single dose, similar to seasonal flu vaccines.

Side effects to the vaccine may include mild fever, body aches and fatigue a few days after injection. People with severe or life-threatening allergies to chicken eggs should not be vaccinated, according the FDA’s Website.

Related posts:

1. Novartis’ Swine Flu Vaccine Tests Well
2. Poll: Most People Seeking Swine Flu Vaccine Can’t Find It
3. Obama Assures Nation Of Vaccine Efforts Ahead Of Second Swine Flu Wave
4. Swine Flu Outbreak – What are the Symptoms?
5. Swine Flu latest: countries issue advisories for United States, Canada